Physician

Kathryn Marie Kent, MD

According to 2025 Medicare claims, Kathryn Kent, MD (NPI: 1811159387) practices dermatology in the Napa, CA market, with the plurality of this provider's patient population coming from Napa, CA. This provider's primary affiliated billing organization is KATHRYN KENT MD (NPI: 1982103487; TIN: 821518564) and primary practice location at 94558-9998.

Kent's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 528 traditional Medicare patients, billed 3,471 HCPCS/CPT codes, and received $230,077 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 440 prescription claims across 185 beneficiaries totaling $67,404 in drug costs, led by Ketoconazole (Ketoconazole). Open Payments data shows 2 records totaling $88. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $96,705 and ending at $230,077. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $6,846 and ending at $67,404. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$228K$455K2015 Medicare payment: $96,705 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $306,629 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $455,159 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $303,159 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $156,308 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $259,607 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $195,704 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $207,904 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $266,858 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $230,077 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015137710$96,705
20164381,816$306,629
20176573,172$455,159
20185622,278$303,159
20193782,095$156,308
20206193,974$259,607
20215173,187$195,704
20225082,913$207,904
20236184,165$266,858
20245283,471$230,077

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$56K$113K2015 Drug cost: $6,846 (USD; Tot_Drug_Cst)2016 Drug cost: $51,129 (USD; Tot_Drug_Cst)2017 Drug cost: $25,182 (USD; Tot_Drug_Cst)2018 Drug cost: $12,476 (USD; Tot_Drug_Cst)2019 Drug cost: $11,459 (USD; Tot_Drug_Cst)2020 Drug cost: $20,852 (USD; Tot_Drug_Cst)2021 Drug cost: $13,540 (USD; Tot_Drug_Cst)2022 Drug cost: $61,038 (USD; Tot_Drug_Cst)2023 Drug cost: $112,897 (USD; Tot_Drug_Cst)2024 Drug cost: $67,404 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154469$6,846
2016173314$51,129
2017188371$25,182
2018139244$12,476
2019129228$11,459
2020214449$20,852
2021158390$13,540
2022152282$61,038
2023195468$112,897
2024185440$67,404

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths192235$113
11102Biopsy of related skin growth, first growth196247$89
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more380533$81
17000Destruction of precancer skin growth, 1 growth279374$49
17003Destruction of precancer skin growth, 2-14 growths2341,516$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KetoconazoleKetoconazole1424,210$2,074
Clindamycin-Benzoyl PeroxideClindamycin Phos/Benzoyl Perox14395$2,040
Clobetasol PropionateClobetasol Propionate381,072$1,534
MetronidazoleMetronidazole14460$960
Triamcinolone AcetonideTriamcinolone Acetonide862,664$689

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$88ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kathryn Marie Kent, MD?

Tedicare shows public-source Medicare data for Kathryn Marie Kent, MD (NPI 1811159387), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kathryn Marie Kent, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kathryn Marie Kent, MD?

Kathryn Marie Kent, MD is linked to KATHRYN KENT MD (billing NPI 1982103487) in the available physician profile data.

Does Kathryn Marie Kent, MD have Open Payments data?

Kathryn Marie Kent, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.